Open Flexible-dose Randomized Study of the Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: A 1-year Follow-up

Trial Profile

Open Flexible-dose Randomized Study of the Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: A 1-year Follow-up

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Mar 2017

At a glance

  • Drugs Aripiprazole (Primary) ; Clonazepam; Olanzapine; Risperidone
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms PAFIP3_1Y
  • Most Recent Events

    • 22 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top